RhumbLine Advisers’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Buy |
|
|||||
|
2025
Q1 | $359K | Sell |
|
|||||
|
2024
Q4 | $1.01M | Buy |
|
|||||
|
2024
Q3 | $1.4M | Sell |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $1.14M | Sell |
|
|||||
|
2023
Q4 | $958K | Buy |
|
|||||
|
2023
Q3 | $1.37M | Sell |
|
|||||
|
2023
Q2 | $1.98M | Buy |
|
|||||
|
2023
Q1 | $1.83M | Buy |
|
|||||
|
2022
Q4 | $1.69M | Buy |
|
|||||
|
2022
Q3 | $2.85M | Buy |
|
|||||
|
2022
Q2 | $3.01M | Buy |
|
|||||
|
2022
Q1 | $3.31M | Sell |
|
|||||
|
2021
Q4 | $4.04M | Buy |
|
|||||
|
2021
Q3 | $4.16M | Buy |
|
|||||
|
2021
Q2 | $2.82M | Buy |
|
|||||
|
2021
Q1 | $2.28M | Buy |
|